Infectious Endophthalmitis After Boston Type 1 Keratoprosthesis Implantation
- 1 April 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cornea
- Vol. 31 (4), 346-349
- https://doi.org/10.1097/ico.0b013e31821eea2f
Abstract
Purpose To determine the incidence, clinical features, and outcomes of infectious endophthalmitis after Boston Type 1 Keratoprosthesis (KPro) implantation. Methods Retrospective, consecutive case series. Chart review of 105 patients (126 eyes) who had KPro implantation at Cincinnati Eye Institute between November 2004 and November 2010 and who were followed up for at least 1 month (range, 1 month to 66 months; mean 25 months) revealed 3 cases who developed infectious endophthalmitis. Results One patient had a history of congenital glaucoma, and 2 patients had Stevens–Johnson syndrome. Two had KPro implantation for penetrating keratoplasty failure and 1 had necrosis of a previous KPro cornea. The incidence of endophthalmitis was 2.4%. All patients wore a contact lens and were on vancomycin and a fourth-generation fluoroquinolone (moxifloxacin). Vitreous fluid cultures yielded Ochrobactrum anthropi, Candida parapsilosis, and Candida albicans. All patients received intravitreal amphotericin, vancomycin, and/or ceftazidime. Topical and oral antiinfective agents were tailored based on sensitivities. One patient required KPro removal and therapeutic penetrating keratoplasty. Vision did not recover for 2 patients who presented with vision decreased to light perception. One patient, who presented with decreased vision of 20/400, recovered to 20/60. Conclusions Infectious endophthalmitis is a devastating complication that can occur after Boston KPro implantation even with prophylactic vancomycin, a fourth-generation fluoroquinolone, and a therapeutic contact lens. Fungal and gram-negative organisms are a growing cause for concern. Further study is needed on optimal prophylaxis regimens, including the use of antifungals, especially for high-risk eyes, such as those with autoimmune cicatrizing disease.Keywords
This publication has 16 references indexed in Scilit:
- The Cincinnati Procedure: Technique and Outcomes of Combined Living-Related Conjunctival Limbal Allografts and Keratolimbal Allografts in Severe Ocular Surface FailureCornea, 2011
- Successful Prevention of Bacterial Endophthalmitis in Eyes with the Boston KeratoprosthesisCornea, 2009
- Characteristics of Endophthalmitis in Patients With the Boston KeratoprosthesisCornea, 2009
- The Boston Keratoprosthesis in Stevens-Johnson SyndromeAmerican Journal of Ophthalmology, 2007
- Fungal Colonization and Infection in Boston KeratoprosthesisCornea, 2007
- Results from the Multicenter Boston Type 1 Keratoprosthesis StudyOphthalmology, 2006
- Bleb-associated endophthalmitis: Clinical characteristics and visual outcomesOphthalmology, 2004
- Endophthalmitis After KeratoprosthesisAmerican Journal of Ophthalmology, 2001
- Non-albicans Candida species isolated from plastic devicesMycopathologia, 1999
- Seven Cases of Bacteremia Due to Ochrobactrum anthropiClinical Infectious Diseases, 1992